{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:42:17Z","timestamp":1785782537402,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T00:00:00Z","timestamp":1446768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T00:00:00Z","timestamp":1446768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Therapies to prevent severe neonatal unconjugated hyperbilirubinemia and kernicterus are phototherapy and, in unresponsive cases, exchange transfusion, which has significant morbidity and mortality risks. Neurotoxicity is caused by the fraction of unconjugated bilirubin not bound to albumin (free bilirubin, Bf). Human serum albumin (HSA) administration was suggested to increase plasma bilirubin-binding capacity. However, its clinical use is infrequent due to difficulties to address its potential preventive and curative benefits and to the absence of reliable markers to monitor bilirubin neurotoxicity risk. We used a genetic mouse model of unconjugated hyperbilirubinemia showing severe neurological impairment and neonatal lethality. We treated mutant pups with repeated HSA administration since birth, without phototherapy application. Daily intraperitoneal HSA administration completely rescued neurological damage and lethality, depending on dosage and administration frequency. Albumin infusion increased plasma bilirubin-binding capacity, mobilizing bilirubin from tissues to plasma. This resulted in reduced plasma Bf, forebrain and cerebellum bilirubin levels. We showed that, in our experimental model, Bf is the best marker to determine the risk of developing neurological damage. These results support the potential use of albumin administration in severe acute hyperbilirubinemia conditions to prevent or treat bilirubin neurotoxicity in situations in which exchange transfusion may be required.<\/jats:p>","DOI":"10.1038\/srep16203","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T11:25:46Z","timestamp":1446809146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Albumin administration prevents neurological damage and death in a mouse model of severe neonatal hyperbilirubinemia"],"prefix":"10.1038","volume":"5","author":[{"given":"Simone","family":"Vodret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bortolussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Ja\u0161prov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libor","family":"Vitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henkjan J.","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F.","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,6]]},"reference":[{"key":"BFsrep16203_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1067\/mpd.2002.123098","volume":"140","author":"LH Johnson","year":"2002","unstructured":"Johnson, L. H., Bhutani, V. K. & Brown, A. K. System-based approach to management of neonatal jaundice and prevention of kernicterus. The Journal of pediatrics 140, 396\u2013403, 10.1067\/mpd.2002.123098 (2002).","journal-title":"The Journal of pediatrics"},{"key":"BFsrep16203_CR2","doi-asserted-by":"crossref","unstructured":"American_Academy_of_Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114, 297\u2013316 (2004).","DOI":"10.1542\/peds.114.1.297"},{"key":"BFsrep16203_CR3","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMra1308124","volume":"369","author":"JF Watchko","year":"2013","unstructured":"Watchko, J. F. & Tiribelli, C. Bilirubin-induced neurologic damage\u2013mechanisms and management approaches. The New England journal of medicine 369, 2021\u20132030, 10.1056\/NEJMra1308124 (2013).","journal-title":"The New England journal of medicine"},{"key":"BFsrep16203_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0009922811398964","volume":"51","author":"AE Burgos","year":"2012","unstructured":"Burgos, A. E., Flaherman, V. J. & Newman, T. B. Screening and follow-up for neonatal hyperbilirubinemia: a review. Clinical pediatrics 51, 7\u201316, 10.1177\/0009922811398964 (2012).","journal-title":"Clinical pediatrics"},{"key":"BFsrep16203_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000330055","volume":"100","author":"M Kaplan","year":"2011","unstructured":"Kaplan, M., Bromiker, R. & Hammerman, C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology 100, 354\u2013362, 10.1159\/000330055 (2011).","journal-title":"Neonatology"},{"key":"BFsrep16203_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/ped.12651","volume":"57","author":"I Morioka","year":"2015","unstructured":"Morioka, I. et al. Current incidence of clinical kernicterus in preterm infants in Japan. Pediatrics international: official journal of the Japan Pediatric Society 57, 494\u2013497, 10.1111\/ped.12651 (2015).","journal-title":"Pediatrics international: official journal of the Japan Pediatric Society"},{"key":"BFsrep16203_CR7","doi-asserted-by":"publisher","first-page":"e925","DOI":"10.1542\/peds.2011-0206","volume":"128","author":"R Gamaleldin","year":"2011","unstructured":"Gamaleldin, R. et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 128, e925\u2013931, 10.1542\/peds.2011-0206 (2011).","journal-title":"Pediatrics"},{"key":"BFsrep16203_CR8","doi-asserted-by":"publisher","first-page":"e1330","DOI":"10.1542\/peds.2013-1764","volume":"134","author":"I Iskander","year":"2014","unstructured":"Iskander, I. et al. Serum bilirubin and bilirubin\/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics 134, e1330\u20131339, 10.1542\/peds.2013-1764 (2014).","journal-title":"Pediatrics"},{"key":"BFsrep16203_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12519-009-0009-2","volume":"5","author":"JA Owa","year":"2009","unstructured":"Owa, J. A. & Ogunlesi, T. A. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World journal of pediatrics: WJP 5, 51\u201355, 10.1007\/s12519-009-0009-2 (2009).","journal-title":"World journal of pediatrics: WJP"},{"key":"BFsrep16203_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.semperi.2011.02.014","volume":"35","author":"TM Slusher","year":"2011","unstructured":"Slusher, T. M., Zipursky, A. & Bhutani, V. K. A global need for affordable neonatal jaundice technologies. Seminars in perinatology 35, 185\u2013191, 10.1053\/j.semperi.2011.02.014 (2011).","journal-title":"Seminars in perinatology"},{"key":"BFsrep16203_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4269\/ajtmh.2003.69.228","volume":"69","author":"M English","year":"2003","unstructured":"English, M. et al. Outcome of delivery and cause-specific mortality and severe morbidity in early infancy: a Kenyan District Hospital birth cohort. The American journal of tropical medicine and hygiene 69, 228\u2013232 (2003).","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"BFsrep16203_CR12","first-page":"299","volume":"33","author":"VC Ezeaka","year":"2004","unstructured":"Ezeaka, V. C., Ekure, E. N., Iroha, E. O. & Egri-Okwaji, M. T. Outcome of low birth weight neonates in a tertiary health care centre in Lagos, Nigeria. African journal of medicine and medical sciences 33, 299\u2013303 (2004).","journal-title":"African journal of medicine and medical sciences"},{"key":"BFsrep16203_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF02761140","volume":"65","author":"JA Owa","year":"1998","unstructured":"Owa, J. A. & Osinaike, A. I. Neonatal morbidity and mortality in Nigeria. Indian journal of pediatrics 65, 441\u2013449 (1998).","journal-title":"Indian journal of pediatrics"},{"key":"BFsrep16203_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/2249-4847.116402","volume":"2","author":"VK Bhutani","year":"2013","unstructured":"Bhutani, V. K. & Wong, R. J. Bilirubin neurotoxicity in preterm infants: risk and prevention. Journal of clinical neonatology 2, 61\u201369, 10.4103\/2249-4847.116402 (2013).","journal-title":"Journal of clinical neonatology"},{"key":"BFsrep16203_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/2249-4847.92239","volume":"1","author":"RC Ibekwe","year":"2012","unstructured":"Ibekwe, R. C., Ibekwe, M. U. & Muoneke, V. U. Outcome of exchange blood transfusions done for neonatal jaundice in abakaliki, South eastern Nigeria. Journal of clinical neonatology 1, 34\u201337, 10.4103\/2249-4847.92239 (2012).","journal-title":"Journal of clinical neonatology"},{"key":"BFsrep16203_CR16","first-page":"367","volume":"52","author":"S Hosseinpour Sakha","year":"2010","unstructured":"Hosseinpour Sakha, S. & Gharehbaghi, M. M. Exchange transfusion in severe hyperbilirubinemia: an experience in northwest Iran. The Turkish journal of pediatrics 52, 367\u2013371 (2010).","journal-title":"The Turkish journal of pediatrics"},{"key":"BFsrep16203_CR17","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1542\/peds.99.5.e7","volume":"99","author":"JC Jackson","year":"1997","unstructured":"Jackson, J. C. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 99, E7 (1997).","journal-title":"Pediatrics"},{"key":"BFsrep16203_CR18","first-page":"417","volume":"75","author":"WJ Keenan","year":"1985","unstructured":"Keenan, W. J., Novak, K. K., Sutherland, J. M., Bryla, D. A. & Fetterly, K. L. Morbidity and mortality associated with exchange transfusion. Pediatrics 75, 417\u2013421 (1985).","journal-title":"Pediatrics"},{"key":"BFsrep16203_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1590\/S0103-05822009000200008","volume":"27","author":"CAM Sa","year":"2009","unstructured":"Sa, C. A. M., Santos, M. C. P., de Carvalho, M. & Moreira, M. E. L. Adverse events related to exchange transfusion in newborn infants with hemolytic disease: ten years of experience. Rev Paul Pediatr 27, 168\u2013172 (2009).","journal-title":"Rev Paul Pediatr"},{"key":"BFsrep16203_CR20","first-page":"163","volume":"52","author":"M Davutoglu","year":"2010","unstructured":"Davutoglu, M., Garipardic, M., Guler, E., Karabiber, H. & Erhan, D. The etiology of severe neonatal hyperbilirubinemia and complications of exchange transfusion. The Turkish journal of pediatrics 52, 163\u2013166 (2010).","journal-title":"The Turkish journal of pediatrics"},{"key":"BFsrep16203_CR21","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0022-2275(20)39768-6","volume":"35","author":"JD Ostrow","year":"1994","unstructured":"Ostrow, J. D., Mukerjee, P. & Tiribelli, C. Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res 35, 1715\u20131737 (1994).","journal-title":"J Lipid Res"},{"key":"BFsrep16203_CR22","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1172\/JCI104813","volume":"42","author":"JD Ostrow","year":"1963","unstructured":"Ostrow, J. D. & Schmid, R. The Protein-Binding of C14-Bilirubin in Human and Murine Serum. The Journal of clinical investigation 42, 1286\u20131299, 10.1172\/JCI104813 (1963).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep16203_CR23","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0021-9258(17)30230-2","volume":"254","author":"R Brodersen","year":"1979","unstructured":"Brodersen, R. Bilirubin. Solubility and interaction with albumin and phospholipid. The Journal of biological chemistry 254, 2364\u20132369 (1979).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep16203_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molmed.2003.12.003","volume":"10","author":"JD Ostrow","year":"2004","unstructured":"Ostrow, J. D., Pascolo, L., Brites, D. & Tiribelli, C. Molecular basis of bilirubin-induced neurotoxicity. Trends in molecular medicine 10, 65\u201370, 10.1016\/j.molmed.2003.12.003 (2004).","journal-title":"Trends in molecular medicine"},{"key":"BFsrep16203_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/jp.2008.199","volume":"29","author":"CE Ahlfors","year":"2009","unstructured":"Ahlfors, C. E., Amin, S. B. & Parker, A. E. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. Journal of perinatology: official journal of the California Perinatal Association 29, 305\u2013309, 10.1038\/jp.2008.199 (2009).","journal-title":"Journal of perinatology: official journal of the California Perinatal Association"},{"key":"BFsrep16203_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/adc.43.228.151","volume":"43","author":"A Comley","year":"1968","unstructured":"Comley, A. & Wood, B. Albumin administration in exchange transfusion for hyperbilirubinaemia. Archives of disease in childhood 43, 151\u2013154 (1968).","journal-title":"Archives of disease in childhood"},{"key":"BFsrep16203_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1651-2227.1982.tb09376.x","volume":"71","author":"F Ebbesen","year":"1982","unstructured":"Ebbesen, F. & Brodersen, R. Comparison between two preparations of human serum albumin in treatment of neonatal hyperbilirubinaemia. Acta paediatrica Scandinavica 71, 85\u201390 (1982).","journal-title":"Acta paediatrica Scandinavica"},{"key":"BFsrep16203_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1046\/j.1442-200X.2002.01612.x","volume":"44","author":"S Hosono","year":"2002","unstructured":"Hosono, S. et al. Follow-up study of auditory brainstem responses in infants with high unbound bilirubin levels treated with albumin infusion therapy. Pediatrics international: official journal of the Japan Pediatric Society 44, 488\u2013492 (2002).","journal-title":"Pediatrics international: official journal of the Japan Pediatric Society"},{"key":"BFsrep16203_CR29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.30.4.613","volume":"30","author":"GB Odell","year":"1962","unstructured":"Odell, G. B., Cohen, S. N. & Gordes, E. H. Administration of albumin in the management of hyperbilirubinemia by exchange transfusions. Pediatrics 30, 613\u2013621 (1962).","journal-title":"Pediatrics"},{"key":"BFsrep16203_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s13312-010-0046-x","volume":"47","author":"M Shahian","year":"2010","unstructured":"Shahian, M. & Moslehi, M. A. Effect of albumin administration prior to exchange transfusion in term neonates with hyperbilirubinemia\u2013a randomized controlled trial. Indian pediatrics 47, 241\u2013244 (2010).","journal-title":"Indian pediatrics"},{"key":"BFsrep16203_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/adc.47.252.250","volume":"47","author":"YC Tsao","year":"1972","unstructured":"Tsao, Y. C. & Yu, V. Y. Albumin in management of neonatal hyperbilirubinaemia. Archives of disease in childhood 47, 250\u2013256 (1972).","journal-title":"Archives of disease in childhood"},{"key":"BFsrep16203_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/adc.45.239.59","volume":"45","author":"B Wood","year":"1970","unstructured":"Wood, B., Comley, A. & Sherwell, J. Effect of additional albumin administration during exchange transfusion on plasma albumin-binding capacity. Archives of disease in childhood 45, 59\u201362 (1970).","journal-title":"Archives of disease in childhood"},{"key":"BFsrep16203_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jhep.2012.08.011","volume":"58","author":"FJ Cuperus","year":"2013","unstructured":"Cuperus, F. J. et al. Beyond plasma bilirubin: the effects of phototherapy and albumin on brain bilirubin levels in Gunn rats. Journal of hepatology 58, 134\u2013140, 10.1016\/j.jhep.2012.08.011 (2013).","journal-title":"Journal of hepatology"},{"key":"BFsrep16203_CR34","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/liv.12219","volume":"33","author":"AB Schreuder","year":"2013","unstructured":"Schreuder, A. B. et al. Albumin administration protects against bilirubin-induced auditory brainstem dysfunction in Gunn rat pups. Liver international: official journal of the International Association for the Study of the Liver 33, 1557\u20131565, 10.1111\/liv.12219 (2013).","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"BFsrep16203_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1203\/PDR.0b013e31817d9be0","volume":"64","author":"AC Rice","year":"2008","unstructured":"Rice, A. C. & Shapiro, S. M. A new animal model of hemolytic hyperbilirubinemia-induced bilirubin encephalopathy (kernicterus). Pediatric research 64, 265\u2013269 (2008).","journal-title":"Pediatric research"},{"key":"BFsrep16203_CR36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1242\/dmm.016535","volume":"7","author":"G Bortolussi","year":"2014","unstructured":"Bortolussi, G. et al. Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in ivo in mice. Disease models & mechanisms 7, 1057\u20131068, 10.1242\/dmm.016535 (2014).","journal-title":"Disease models & mechanisms"},{"key":"BFsrep16203_CR37","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1096\/fj.11-195461","volume":"26","author":"G Bortolussi","year":"2012","unstructured":"Bortolussi, G. et al. Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26, 1052\u20131063, 10.1096\/fj.11-195461 (2012).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"BFsrep16203_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali, G. et al. Human serum albumin: from bench to bedside. Molecular aspects of medicine 33, 209\u2013290, 10.1016\/j.mam.2011.12.002 (2012).","journal-title":"Molecular aspects of medicine"},{"key":"BFsrep16203_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1172\/JCI103868","volume":"38","author":"H Bennhold","year":"1959","unstructured":"Bennhold, H. & Kallee, E. Comparative studies on the half-life of I 131-labeled albumins and nonradioactive human serum albumin in a case of analbuminemia. The Journal of clinical investigation 38, 863\u2013872, 10.1172\/JCI103868 (1959).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep16203_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF01712175","volume":"22","author":"A Greissman","year":"1996","unstructured":"Greissman, A., Silver, P., Nimkoff, L. & Sagy, M. Albumin bolus administration versus continuous infusion in critically ill hypoalbuminemic pediatric patients. Intensive care medicine 22, 495\u2013499 (1996).","journal-title":"Intensive care medicine"},{"key":"BFsrep16203_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1084\/jem.20021829","volume":"197","author":"C Chaudhury","year":"2003","unstructured":"Chaudhury, C. et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. The Journal of experimental medicine 197, 315\u2013322 (2003).","journal-title":"The Journal of experimental medicine"},{"key":"BFsrep16203_CR42","doi-asserted-by":"publisher","first-page":"13492","DOI":"10.1074\/jbc.M114.549832","volume":"289","author":"JT Andersen","year":"2014","unstructured":"Andersen, J. T. et al. Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding. The Journal of biological chemistry 289, 13492\u201313502, 10.1074\/jbc.M114.549832 (2014).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep16203_CR43","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","volume":"285","author":"JT Andersen","year":"2010","unstructured":"Andersen, J. T., Daba, M. B., Berntzen, G., Michaelsen, T. E. & Sandlie, I. Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. The Journal of biological chemistry 285, 4826\u20134836, 10.1074\/jbc.M109.081828 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep16203_CR44","first-page":"399","volume":"50","author":"R Caldera","year":"1993","unstructured":"Caldera, R. et al. [The effect of human albumin in association with intensive phototherapy in the management of neonatal jaundice]. Archives francaises de pediatrie 50, 399\u2013402 (1993).","journal-title":"Archives francaises de pediatrie"},{"key":"BFsrep16203_CR45","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMoa0803024","volume":"359","author":"BH Morris","year":"2008","unstructured":"Morris, B. H. et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. The New England journal of medicine 359, 1885\u20131896, 10.1056\/NEJMoa0803024 (2008).","journal-title":"The New England journal of medicine"},{"key":"BFsrep16203_CR46","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1542\/peds.2007-2297","volume":"121","author":"CE Ahlfors","year":"2008","unstructured":"Ahlfors, C. E. & Parker, A. E. Unbound bilirubin concentration is associated with abnormal automated auditory brainstem response for jaundiced newborns. Pediatrics 121, 976\u2013978, 10.1542\/peds.2007-2297 (2008).","journal-title":"Pediatrics"},{"key":"BFsrep16203_CR47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.93.3.488","volume":"93","author":"CE Ahlfors","year":"1994","unstructured":"Ahlfors, C. E. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 93, 488\u2013494 (1994).","journal-title":"Pediatrics"},{"key":"BFsrep16203_CR48","doi-asserted-by":"publisher","first-page":"e99466","DOI":"10.1371\/journal.pone.0099466","volume":"9","author":"CV Hulzebos","year":"2014","unstructured":"Hulzebos, C. V. et al. The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial\u2013BARTrial. PloS one 9, e99466, 10.1371\/journal.pone.0099466 (2014).","journal-title":"PloS one"},{"key":"BFsrep16203_CR49","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1442-200X.2009.02878.x","volume":"51","author":"YK Lee","year":"2009","unstructured":"Lee, Y. K., Daito, Y., Katayama, Y., Minami, H. & Negishi, H. The significance of measurement of serum unbound bilirubin concentrations in high-risk infants. Pediatrics international: official journal of the Japan Pediatric Society 51, 795\u2013799, 10.1111\/j.1442-200X.2009.02878.x (2009).","journal-title":"Pediatrics international: official journal of the Japan Pediatric Society"},{"key":"BFsrep16203_CR50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1442-200X.1992.tb01024.x","volume":"34","author":"H Nakamura","year":"1992","unstructured":"Nakamura, H., Yonetani, M., Uetani, Y., Funato, M. & Lee, Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta paediatrica Japonica; Overseas edition 34, 642\u2013647 (1992).","journal-title":"Acta paediatrica Japonica; Overseas edition"},{"key":"BFsrep16203_CR51","doi-asserted-by":"crossref","unstructured":"Morioka, I. et al. Serum unbound bilirubin as a predictor for clinical kernicterus in extremely low birth weight infants at a late age in the neonatal intensive care unit. Brain & development, 10.1016\/j.braindev.2015.01.001 (2015).","DOI":"10.1016\/j.braindev.2015.01.001"},{"key":"BFsrep16203_CR52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1651-2227.2010.01688.x","volume":"99","author":"W Oh","year":"2010","unstructured":"Oh, W. et al. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta paediatrica 99, 673\u2013678, 10.1111\/j.1651-2227.2010.01688.x (2010).","journal-title":"Acta paediatrica"},{"key":"BFsrep16203_CR53","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/hum.2013.233","volume":"25","author":"G Bortolussi","year":"2014","unstructured":"Bortolussi, G. et al. Life-Long Correction of Hyperbilirubinemia with a Neonatal Liver-Specific AAV-Mediated Gene Transfer in a Lethal Mouse Model of Crigler-Najjar Syndrome. Human gene therapy 25, 844\u2013855, 10.1089\/hum.2013.233 (2014).","journal-title":"Human gene therapy"},{"key":"BFsrep16203_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2005.07.030","volume":"365","author":"CE Ahlfors","year":"2006","unstructured":"Ahlfors, C. E., Marshall, G. D., Wolcott, D. K., Olson, D. C. & Van Overmeire, B. Measurement of unbound bilirubin by the peroxidase test using Zone Fluidics. Clinica chimica acta; international journal of clinical chemistry 365, 78\u201385, 10.1016\/j.cca.2005.07.030 (2006).","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"BFsrep16203_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jchromb.2008.03.005","volume":"867","author":"J Zelenka","year":"2008","unstructured":"Zelenka, J. et al. Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 867, 37\u201342, 10.1016\/j.jchromb.2008.03.005 (2008).","journal-title":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16203","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:04:56Z","timestamp":1672923896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]}},"alternative-id":["BFsrep16203"],"URL":"https:\/\/doi.org\/10.1038\/srep16203","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,6]]},"assertion":[{"value":"24 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16203"}}